{"id":"https://openalex.org/W4366285231","doi":"https://doi.org/10.18502/aptj.v3i1.12501","title":"Preparation of Thymol Nanoliposome and Solid Lipid Nanoparticle and Evaluation of their Inhibitory Effects on Leishmania Major Promastigotes","display_name":"Preparation of Thymol Nanoliposome and Solid Lipid Nanoparticle and Evaluation of their Inhibitory Effects on Leishmania Major Promastigotes","alternate_titles":[],"publication_year":2023,"publication_date":"2023-04-17","ids":{"openalex":"https://openalex.org/W4366285231","doi":"https://doi.org/10.18502/aptj.v3i1.12501"},"language":"en","primary_location":{"id":"doi:10.18502/aptj.v3i1.12501","doi":"https://doi.org/10.18502/aptj.v3i1.12501","is_oa":false,"landing_page_url":"https://doi.org/10.18502/aptj.v3i1.12501","pdf_url":null,"source":{"id":"https://openalex.org/S4210185282","display_name":"Advances in Pharmacology and Therapeutics Journal","issn_l":"2783-3445","issn":["2783-3445"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319396","host_organization_name":"Knowledge E","host_organization_lineage":["https://openalex.org/P4310319396"],"host_organization_lineage_names":["Knowledge E"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Pharmacology and Therapeutics Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4366285231"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008552580","display_name":"Mohsen Zabihi","orcid":"https://orcid.org/0000-0002-8929-3684","observed_orcids":["https://orcid.org/0000-0002-8929-3684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohsen Zabihi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038659443","display_name":"Mahdiyeh Shafaei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahdiyeh Shafaei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021875895","display_name":"Vahid Ramezani","orcid":"https://orcid.org/0000-0003-4791-6182","observed_orcids":["https://orcid.org/0000-0003-4791-6182"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vahid Ramezani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070066594","display_name":"Tahereh Dara","orcid":"https://orcid.org/0000-0002-2609-0492","observed_orcids":["https://orcid.org/0000-0002-2609-0492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tahereh Dara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025855826","display_name":"Farzaneh Mirzaie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farzaneh Mirzaie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.105,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.73706669,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.8057000041007996,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.8057000041007996,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.11069999635219574,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.06930000334978104,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thymol","display_name":"thymol","score":0.996999979019165},{"id":"https://openalex.org/keywords/nanoliposomes","display_name":"nanoliposomes","score":0.9269999861717224},{"id":"https://openalex.org/keywords/solid-lipid-nanoparticles","display_name":"solid lipid nanoparticles","score":1.0},{"id":"https://openalex.org/keywords/antiprotozoal-activity","display_name":"antiprotozoal activity","score":0.843999981880188},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.5830000042915344},{"id":"https://openalex.org/keywords/drug-loading-efficiency","display_name":"drug loading efficiency","score":0.5289999842643738},{"id":"https://openalex.org/keywords/drug-release-profile","display_name":"drug release profile","score":0.6299999952316284},{"id":"https://openalex.org/keywords/phosphatidylcholine","display_name":"phosphatidylcholine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/glycerol-monostearate","display_name":"glyceryl monostearate","score":0.972000002861023},{"id":"https://openalex.org/keywords/leishmaniasis","display_name":"leishmaniasis","score":0.7480000257492065},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.6470000147819519},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.5220000147819519},{"id":"https://openalex.org/keywords/nanoparticle-formulation-optimization","display_name":"nanoparticle formulation optimization","score":0.6859999895095825},{"id":"https://openalex.org/keywords/zeta-potential","display_name":"zeta potential","score":0.7829999923706055},{"id":"https://openalex.org/keywords/particle-size","display_name":"particle size","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C2780642067","wikidata":"https://www.wikidata.org/wiki/Q408883","display_name":"Thymol","level":3,"score":0.9521422386169434},{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.8445205688476562},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.6831691265106201},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6339769959449768},{"id":"https://openalex.org/C2776330855","wikidata":"https://www.wikidata.org/wiki/Q650187","display_name":"Phosphatidylcholine","level":4,"score":0.4997117519378662},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.49831223487854004},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.4955826997756958},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.4758738577365875},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4535239636898041},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.443327397108078},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33378905057907104},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.16580289602279663},{"id":"https://openalex.org/C2777278459","wikidata":"https://www.wikidata.org/wiki/Q170885","display_name":"Essential oil","level":2,"score":0.16550800204277039},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.16546744108200073},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.15967482328414917},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.13956281542778015},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.18502/aptj.v3i1.12501","doi":"https://doi.org/10.18502/aptj.v3i1.12501","is_oa":false,"landing_page_url":"https://doi.org/10.18502/aptj.v3i1.12501","pdf_url":null,"source":{"id":"https://openalex.org/S4210185282","display_name":"Advances in Pharmacology and Therapeutics Journal","issn_l":"2783-3445","issn":["2783-3445"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319396","host_organization_name":"Knowledge E","host_organization_lineage":["https://openalex.org/P4310319396"],"host_organization_lineage_names":["Knowledge E"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Pharmacology and Therapeutics Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7166574129","https://openalex.org/W4287496941","https://openalex.org/W2262263791","https://openalex.org/W4379988245","https://openalex.org/W4313326096","https://openalex.org/W4375847260","https://openalex.org/W2980505583","https://openalex.org/W2887204739","https://openalex.org/W2397248576","https://openalex.org/W3039879430"],"abstract_inverted_index":{"Introduction:":[0],"Thymol":[1,272],"has":[2,177,273],"an":[3],"antiprotozoal":[4],"effect.":[5],"Nanoparticulate":[6],"systems":[7],"are":[8,245],"useful":[9],"carriers":[10],"for":[11,101,207,241,258,266],"both":[12],"small":[13],"and":[14,25,45,54,70,76,87,99,104,116,140,203,220,237,248,256,261,264,284,302],"large":[15],"drug":[16,32,300],"molecules,":[17],"which":[18,111,210,251],"can":[19,297],"protect":[20],"them":[21,58],"from":[22],"some":[23],"chemical":[24],"biological":[26],"damages":[27],"as":[28,30],"well":[29],"target":[31],"delivery":[33],"to":[34,165,188,253],"specific":[35],"organs":[36],"or":[37,293],"receptors.":[38],"In":[39],"this":[40,184],"work,":[41],"the":[42,55,77,93,117,133,142,146,154,167,189,278,289,299,308],"nano-liposomal":[43],"system":[44],"solid":[46,71,143,195,221,238,294],"lipid":[47,72,144,196,222,239,295],"nanoparticles":[48,73,197,223,240,296],"loaded":[49],"by":[50],"thymol":[51,80,126,159,287],"were":[52,59,74,90,96,119,163,205],"prepared":[53,148],"effectiveness":[56],"of":[57,68,79,125,158,170,191,216,233,269,280,286,291],"evaluated":[60],"on":[61,107,113,277],"Leishmania":[62,108,225,281],"major":[63,109,282],"promastigotes.":[64],"Methods:":[65],"Several":[66],"formulations":[67,95,134,162],"nano-liposomes":[69,128],"prepared,":[75],"amount":[78],"loading,":[81],"in-vitro":[82],"release":[83,168,180,301],"profile,":[84],"particle":[85],"size,":[86],"zeta":[88],"potential":[89],"evaluated.":[91],"Finally,":[92],"best":[94,200],"serially":[97],"diluted":[98],"incubated":[100],"24,":[102],"48,":[103],"72":[105,267],"hours":[106,260,268],"promastigotes,":[110],"cultured":[112],"Novy\u2013MacNeal\u2013Nicolle":[114],"medium,":[115],"results":[118,173],"analyzed.":[120],"Results:":[121],"The":[122,172,199,227],"highest":[123],"loading":[124],"in":[127,132,194,288],"(92%)":[129],"was":[130],"seen":[131],"made":[135],"with":[136,149],"phosphatidylcholine":[137],"(Called":[138],"L3),":[139],"among":[141],"nanoparticles,":[145],"formulation":[147],"glycerol":[150],"monostearate":[151,193],"(S1)":[152],"had":[153],"most":[155],"entrapment":[156],"efficiency":[157],"(87%).":[160],"These":[161],"selected":[164],"evaluate":[166],"rate":[169,181],"thymol.":[171],"showed":[174,211],"that":[175,212],"S1":[176],"a":[178,242,274,304],"slower":[179],"than":[182],"L3;":[183],"may":[185],"be":[186],"due":[187],"presence":[190],"Glycerol":[192],"structure.":[198],"formulations,":[201],"L3":[202],"S1,":[204],"chosen":[206],"anti-Leishmaniosis":[208],"assessment;":[209],"all":[213],"three":[214],"forms":[215],"free":[217,234],"thymol,":[218,235],"nanoliposomes,":[219],"inhibited":[224],"major.":[226],"half":[228],"maximal":[229],"inhibitory":[230],"concentration":[231],"(IC50)":[232],"nanoliposome,":[236],"24-hour":[243],"incubation":[244,310],"7.8,":[246,254,255,262],"62.5,":[247],"125,":[249],"respectively,":[250],"decrease":[252],"15.6":[257],"48":[259],"0.49,":[263],"0":[265],"incubation.":[270],"Conclusion:":[271],"significant":[275],"effect":[276],"inhibition":[279],"promastigotes":[283],"usage":[285],"form":[290],"liposomes":[292],"sustain":[298],"have":[303],"lower":[305],"IC50":[306],"during":[307],"longer":[309],"time.":[311]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4366285231","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-20T00:00:00"}
